On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat
Y. Tan et al., On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat, BRAIN RES, 869(1-2), 2000, pp. 56-68
Calbindin-D 28kD is a calcium binding protein reported to protect neurons f
rom degeneration by buffering intracellular calcium. It is expressed in mid
brain dopaminergic neurons reported to be relatively resistant to degenerat
ion in Parkinson's disease and certain of its animal models. Lesions of the
nigrostriatal pathway produced in rats following injection of 6-hydroxydop
amine result in a neurochemical profile similar to that seen in patients wi
th Parkinson's disease. In the present study, brains were processed to exhi
bit tyrosine hydroxylase- and calbindin-D 28kD immunoreactivities in sectio
ns through the ventral mesencephalon at 3, 7, 10, 14 and 21 days after 6-hy
droxydopamine had been injected into the medial forebrain bundle. Numbers o
f ventral mesencephalic calbindin-D 28kD immunoreactive neurons were signif
icantly reduced ipsilateral to the lesions at 3 days post-lesion and, follo
wing slight recovery, remained significantly depleted through post-lesion d
ay 21. The densities of calbindin-D 28kD and tyrosine hydroxylase immunorea
ctive neurons were different only at the 3 day post-lesion time point, when
the apparent loss of calbindin-D 28 kD immunoreactive profiles was signifi
cantly greater. A lesion-induced increase in the proportion of neurons exhi
biting both calbindin-D 28kD and tyrosine hydroxylase immunoreactivities, e
xpected if calbindin-D 28kD is neuroprotective, was observed in the substan
tia nigra, pars compacta, bur not in the ventral tegmental area. It is conc
luded that, while the observed losses of tyrosine hydroxylase and calbindin
-D 28kD immunoreactivities do not necessarily reflect neuronal degeneration
, they are not consistent with CB confering a neuroprotective advantage in
the ventral tegmental area following 6-OHDA lesions as administered in this
study. (C) 2000 Elsevier Science B.V. All rights reserved.